Arabic Arabic English English French French German German

Researchers shine light on a rare form of kidney cancer

Translocation renal cell carcinoma (tRCC) is a rare and aggressive form of kidney cancer. It accounts for about 5 percent of all renal cell carcinomas in adults and about 50 percent in children. Relatively little is known about this cancer subtype, including its molecular underpinnings and the best course of clinical treatment. In a new comprehensive, multicenter study of 152 samples, investigators at Dana-Farber Brigham Cancer Center helped to illuminate the disease’s molecular landscape and clinical features, finding that genetic alterations are rare in tRCC, except for the gene fusion from which it gets its name. Their work further suggests that tRCCs may be responsive to treatment with immune checkpoint inhibitors. Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Boosting the maternal microbiome sharply reduces biliary atresia risk, finds early-stage study

Next Post

Epigenetic aging clock predicts the biological age of individual cells

Related Posts